Intrathecal infusion therapy with dexmedetomidine-supplemented morphine in cancer pain
Yükleniyor...
Dosyalar
Tarih
2007
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Blackwell Publishing
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Sir, Pain is one of the most important symptoms of end-stage cancer that needs to be controlled. Dexmedetomidine is an alpha2 agonist with sedative and analgesic properties (1). Intrathecal dexmedetomidine for the relief of cancer pain has not been
reported in the literature previously. In this communication, the use of intrathecal dexmedetomidine-supplemented morphine is reported in a patient with cancer.
Açıklama
Anahtar Kelimeler
Cancer Pain
Kaynak
Acta Anaesthesiologica Scandinavica
WoS Q Değeri
Q2
Scopus Q Değeri
Q1
Cilt
51
Sayı
3